Sunho（china）biopharmaceutical Co., Ltd.
Clinical trials sponsored by Sunho（china）biopharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New lupus drug candidate ISH0613 enters first human safety trial Results expected Dec 2026 (estimated)
- New shot aims to lower high blood fats in early human test Results expected Feb 2027 (estimated)
-
New shot aims to lower high blood fats in early human test
Disease control Not yet recruitingThis early-stage study tests a new medicine called ISH0688, given as a shot under the skin, for people with high triglycerides (a type of blood fat). The study will involve 104 healthy volunteers and people with high triglycerides to check the drug's safety and how the body proce…
Phase 1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New lupus drug candidate ISH0613 enters first human safety trial
Knowledge-focused Not yet recruitingThis early-stage trial is the first time ISH0613 will be given to humans. It aims to check the drug's safety and how it moves through the body in 26 healthy Chinese adults. Participants receive a single intravenous dose of either ISH0613 or a placebo and are closely monitored for…
Phase 1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC